ATE489971T1 - Ionaustausch-tumor zielausrichtung - Google Patents

Ionaustausch-tumor zielausrichtung

Info

Publication number
ATE489971T1
ATE489971T1 AT99970330T AT99970330T ATE489971T1 AT E489971 T1 ATE489971 T1 AT E489971T1 AT 99970330 T AT99970330 T AT 99970330T AT 99970330 T AT99970330 T AT 99970330T AT E489971 T1 ATE489971 T1 AT E489971T1
Authority
AT
Austria
Prior art keywords
ion exchange
tumor targeting
tumor
compound
intratumoral
Prior art date
Application number
AT99970330T
Other languages
English (en)
Inventor
Anders Holmberg
Original Assignee
Dextech Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dextech Medical Ab filed Critical Dextech Medical Ab
Application granted granted Critical
Publication of ATE489971T1 publication Critical patent/ATE489971T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99970330T 1998-10-13 1999-10-12 Ionaustausch-tumor zielausrichtung ATE489971T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9803482A SE9803482D0 (sv) 1998-10-13 1998-10-13 Ion exchange tumor targeting (IETT)
PCT/SE1999/001837 WO2000021571A1 (en) 1998-10-13 1999-10-12 Ion exchange tumor targeting (iett)

Publications (1)

Publication Number Publication Date
ATE489971T1 true ATE489971T1 (de) 2010-12-15

Family

ID=20412924

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99970330T ATE489971T1 (de) 1998-10-13 1999-10-12 Ionaustausch-tumor zielausrichtung

Country Status (11)

Country Link
US (1) US6569841B1 (de)
EP (1) EP1137441B1 (de)
JP (1) JP2002527407A (de)
AT (1) ATE489971T1 (de)
AU (1) AU759251B2 (de)
CA (1) CA2347424C (de)
DE (1) DE69943003D1 (de)
IL (1) IL142292A0 (de)
NO (1) NO20011817D0 (de)
SE (1) SE9803482D0 (de)
WO (1) WO2000021571A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20010764A0 (fi) * 2001-04-11 2001-04-11 Map Medical Technologies Oy Kationiset dekstraanijohdannaiset käytettäväksi munuaisten suojaamiseen
US8377484B1 (en) 2004-05-06 2013-02-19 Maria V. Tsiper Tumor encapsulation for prevention and treatment of metastatic cancer disease
RU2008144129A (ru) * 2006-04-07 2010-05-20 Адосиа (Fr) Бифункционализованные полисахариды
FI119513B (fi) 2007-03-07 2008-12-15 Dextech Medical Ab Muokatut hydroksipolymeerikonjugaatit, joilla on tappava vaikutus tuumorisoluihin
FR2919189A1 (fr) 2007-07-26 2009-01-30 Cyclopharma Sa Lab Nouvelles compositions a base de polyosides greffes par des composes polyamines ou polysoufres.
US7998368B2 (en) * 2007-11-26 2011-08-16 United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Aqueous solution dispersement of carbon nanotubes
WO2009124580A1 (en) * 2008-04-07 2009-10-15 Dextech Medical Ab Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties
KR101450838B1 (ko) 2012-02-08 2014-10-15 가톨릭대학교 산학협력단 표적화 화학요법을 위한 암 인식 지능형 폴리펩티드 및 이의 제조방법
DE102014016901B4 (de) * 2014-09-17 2021-08-12 Friedrich-Schiller-Universität Jena Verfahren zur Herstellung für neue Dextranderivate als Wirkstoffträgersystem und deren Verwendung
FI127538B (en) 2016-06-22 2018-08-31 Dextech Medical Ab MODIFIED Dextran Conjugates
PL240772B1 (pl) * 2018-06-11 2022-06-06 Nanothea Spolka Akcyjna Sposób wytwarzania nanocząstek polimerowych chelatujących izotopy promieniotwórcze do zastosowania w diagnostyce i terapii

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051257A (en) * 1989-05-09 1991-09-24 Pietronigro Dennis D Antineoplastic solution and method for treating neoplasms

Also Published As

Publication number Publication date
CA2347424C (en) 2009-12-08
EP1137441A1 (de) 2001-10-04
AU1424700A (en) 2000-05-01
JP2002527407A (ja) 2002-08-27
EP1137441B1 (de) 2010-12-01
SE9803482D0 (sv) 1998-10-13
WO2000021571A1 (en) 2000-04-20
NO20011817L (no) 2001-04-10
US6569841B1 (en) 2003-05-27
NO20011817D0 (no) 2001-04-10
IL142292A0 (en) 2002-03-10
CA2347424A1 (en) 2000-04-20
AU759251B2 (en) 2003-04-10
DE69943003D1 (de) 2011-01-13

Similar Documents

Publication Publication Date Title
DE69828436D1 (de) Radioaktive embolisierende zusammensetzungen
CY1109881T1 (el) Νεοαγγειακα-συγκεκριμενα πεπτιδια
ATE489971T1 (de) Ionaustausch-tumor zielausrichtung
ES2141128T3 (es) Combinacion de agentes anti-hormonales y moleculas de fijacion.
WO2004111192A3 (en) Targeted delivery to legumain-expressing cells
HK1038929A1 (en) Cancer antigens based on tumor suppressor gene wt1product.
DE60224816D1 (de) Subzelluläres targeting von therapeutischen proteinen
BR9808881A (pt) Compostos para imunoterapia de câncer de próstata e métodos para seu uso
DE69737867D1 (de) Zielgerichtete kombinations-immuntherapie für krebs
BR0010590A (pt) Emprego de filanto para estimulação objetivada do sistema imunológico
TR199901949T2 (xx) Lemfositik t�m�rler i�in �areler.
ATE316134T1 (de) Zusammensetzung mit alpha-glycosylceramid zur stärkung zellulärer immunogenität
BR0208017A (pt) Combinação compreendendo combretastatina e agentes anticâncer
WO2000045853A3 (en) Treatment of tumors with genetically engineered herpes virus
WO2004110255A3 (en) Antineoplastic agents targeted via glut transporters
WO2002058538A3 (en) Methods of imaging and targeting vasculature
NZ309171A (en) use of apoptin as an antitumour agent which specifically kills tumour and not normal cells
WO1999002704A3 (en) Dual specifically phosphatase and methods of use
AU3260093A (en) Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours
WO2005007079A3 (en) Inactivators and bivalent inhibitors of glyoxalase i and methods of inhibiting tumor growth
WO2000040752A3 (en) Cancer associated genes and their products
TW200517125A (en) Pharmaceutical composition for treatment of solid cancers
DE60235085D1 (de) Herstellungsverfahren von derivate von bisphosphonaten
WO2000078361A3 (en) Methods of imaging and targeting tumor vasculature
EA200100311A1 (ru) Бифункциональные антитела и их применение для прицельной доставки противоопухолевых средств

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties